AI news
Albert Invent announces $55 million Series B for chemistry AI
Albert Invent announced a $55 million Series B led by TCV for its chemistry-focused R&D platform. Its Valence model and Ask Albert workflow are described as existing product capabilities, with new company research claiming better chemical-query retrieval. The announcement does not disclose a financing valuation or independently prove its benchmark and adoption claims.
Primary source · Albert Invent · October 13, 2026
Opens Albert Invent in a new tab. Read it there before you rely on the summary above.
Read the original
Free, email only
Unlock the full brief free.
- What to check before you trust this story, written down
- Each verified source, with why it matters and who published it
- A note whenever a source has been withdrawn
- Thirty days of stories to browse, not seven
Continuing subscribes the email on that account to the Rise Productive newsletter, the same as the form below, and unlocks every free tool in this browser. We only receive your email address. Unsubscribe in one click.